Clinical Trials

Accrual Status
Limit to SWOG Trials

1033 Results

Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
Closed SWOG-8805 Neoadjuvant Cisplatin and VP-16 Plus Concurrent Chest and Optional Brain Irradiation for Patients with Stage lll Non-Small Cell Lung Carcinoma 7/1/1988 3/15/1992 100% Published
Closed S1619 Neoadjuvant Cisplatin-Pemetrexed with Atezolizumab 11/3/2017 5/1/2020 100%
Closed SWOG-8704 Neoadjuvant Methotrexate, Cisplatin and Vinblastine (MCV) Followed by Concomitant Cisplatin/Radiotherapy for Unresectable Localized Bladder Cancer Patients 9/1/1987 8/15/1991 90% Published
Closed S0012 NEOADJUVANT: Standard AC vs. Weekly A and Daily Oral C + G-CSF 5/1/2001 12/1/2005 100% Published
Closed S0925 New Hormone-Sensitive Metastatic PCa, Androgen Deprivation +/- IMC-A12, Ph II 12/15/2010 12/1/2012 100% Published
Closed S0204 Newly Diagnosed Multiple Myeloma Tandem Transplant 6/15/2002 10/15/2005 100% Published
Closed SWOG-7204/7205 Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance 4/17/1972 9/10/1974 Published
Closed SWOG-7433 Non-Hodgkin's Lymphomas (Stages I, IE, II, and IIE) 12/27/1974 1/29/1981 Published
Closed S0108 NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL 4/15/2001 12/1/2004 87% Published
Closed S0313 NON-HODGKIN'S: CHOP + IF RT followed by Yttrium-90 Ibritumomab Tiuxetan 2/1/2004 12/15/2008 77% Published
Closed S0349 NON-HODGKIN'S: CHOP plus G3139 for Adv Stage Large B-cell of Low and Low-Int IPI Risk 3/1/2004 5/15/2006 10%
Closed S0014 NON-HODGKIN'S: CHOP with concurrent rituximab plus IFR 4/1/2000 1/15/2002 100% Published
Closed S9704 NON-HODGKIN'S: CHOP x 8 vs. CHOP x 6 followed by TBI/VP-6/cylophosphamide or SWOG BCV with stem cell rescue 9/15/1997 12/15/2007 100% Published
Closed S0016 NON-HODGKIN'S: CHOP/rituximab vs. CHOP/tositumomab 3/1/2001 10/2/2008 100% Published
Closed SWOG-9438 NON-HODGKIN'S: Debulking salvage chemo adn stem cell harvest -> TBI/cyclophosphamide -> PBSCT and randmization to IL-2 or obs. 5/15/1995 7/1/2004 98% Published
Closed S0019 NON-HODGKIN'S: ICE +/- Rituxan for Relapsed/Refractory CD20+ B-Cell NHL 10/15/2000 12/15/2001 2% Published
Closed S0515 NON-HODGKIN'S: R-CHOP + Bevacizumab for Adv Stage Diffuse Large B-cell NHL 6/15/2005 9/15/2008 100% Published
Closed S0801 NON-HODGKIN: Bexxar + CHOP-Rituximab for Advanced Follicular NHL 4/1/2009 12/15/2010 100%
Closed S0350 NON-HODGKIN: PEGS treatment for Peripheral T-Cell NHL 9/15/2005 12/1/2010 100% Published
Closed S0520 NON-HODGKIN: PXD101 Therapy for B-Cell Lymphoma 1/1/2006 5/1/2009 55% Published
Scroll Table